Pidilizumab Biosimilar – Anti-PDCD1, CD279 mAb – Research Grade

Reference:
Product namePidilizumab Biosimilar - Anti-PDCD1, CD279 mAb - Research Grade
SourceCAS 1036730-42-3
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsPidilizumab,CT-011,PDCD1, CD279,anti-PDCD1, CD279
ReferencePX-TA1312
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Pidilizumab Biosimilar - Anti-PDCD1/CD279 mAb - Research Grade

General information on Anti-PDCD1/CD279[Homo sapiens] (Pidilizumab) Monoclonal Antibody

Pidilizumab is investigated for treatments of Diffuse Intrinsic Pontine Glioma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Pidilizumab Biosimilar – Anti-PDCD1, CD279 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human PDL1, B7-H1, CD274 recombinant protein
Antigen

Human PDL1, B7-H1, CD274 recombinant protein

PX-P4038 221$
Human Programmed cell death protein 1 recombinant protein (PDCD1)
Antigen

Human Programmed cell death protein 1 recombinant protein (PDCD1)

PX-P4028 221$
Programmed cell death 1 ligand 1(Cd274)
Antigen

Programmed cell death 1 ligand 1(Cd274)

PX-P4580 221$
Human PD-L2 recombinant protein
Antigen

Human PD-L2 recombinant protein

PX-P6014 404$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 189$
Stable Isotope Labelled Pidilizumab Biosimilar – Anti-PDCD1/CD279 mAb – Research Grade
SIL

Stable Isotope Labelled Pidilizumab Biosimilar – Anti-PDCD1/CD279 mAb – Research Grade

PX-TA1312-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products